Suspension cultures of human umbilical cord blood mononuclear cells supplemented with c-kit ligand-containing additives give rise to a mixture of cells belonging to several lineages. Among those that differentiate in quantity are mature basophils, immature mast cells, and neutrophilic myelocytes. We used an ultrastructural immunogold method to detect the Charcot-Leyden crystal (CLC) protein, an eosinophiland basophil-specific protein, to study cells that were obtained at sequential times from 3 to 14 weeks in culture. Basophils (and eosinophils, which were present in smaller numbers) labeled for the CLC protein; mast cells did not. The labeled basophil subcellular sites included formed intragranular, cytoplasmic and nuclear CLCs, cytoplasmic particle-filled and homogeneously dense granules, cytoplasm, nucleus, plasma membrane, and cytoplasmic and ' S~p p d by PHS grants AI-33372, AI-lO060, AI-25230, and AI-22660. Golgi area vesicles. Individual basophil u l t r a s a u d phenotypes similar to those associated with stimulated release and recovery reactions showed the expected variations in the goldlabeled subcellular compartments. Macrophages also were labeled for CLC protein within endocytotic-lysosomal stuctures; neutrophilicmyelocytes did not contain CLC protein. On the basis of findings reported here, the combined ultrastructural morphology and immunogold phenotyping of cells differentiating in c-kit ligand-supplemented cultures allows accurate lineage assignment of the developing cells. (]Histo-&em Cytochem 42251-263, 1994)
Introduction
Human basophils and mast cells can now be reliably induced to develop in vitro from their agranular precursors which are present in cord blood (1) (2) (3) (4) (5) (6) . Initially, these studies were done with supplements of various cell-conditioned media now known to contain a basophil growth factor, interleukin-3 (IL3) (l), or a mast cell growth factor, the c-kit ligand [also called stem cell factor (SCF)] (5, 6) . Some of these studies were also done with cord blood cells cocultured with mouse 3T3 fibroblasts (3, 4) . When partially purified murine fibroblast factor(s) [MFF(s)] (5) and recombinant factors (2,5) became available, the cord blood suspension cultures were repeated with these reagents. In all of these cultures, ultrastructural criteria were used to assign immature and mature cells to the appropriate lineages (1-5) (AM Dvorak et al., unpublished data).
Charcot-Leyden crystals (CLCs) are hexagonal, bipyramidal structures originally described in eosinophil-rich disorders (7, 8) . CLC protein is the sole protein constituent of CLCs purified from human eosinophils; it expresses lysophospholipase activity, forms these characteristic crystals, and comprises an estimated 7-10% of total cellular protein in the eosinophil (9) (10) (11) (12) . CLCs and the CLC protein, once considered unique to the eosinophil lineage, have also been found in human basophils (2, 13, 14) . Using an ultrastructural immunogold method, we have defined the subcellular locations of the CLC protein in quiescent peripheral blood eosinophils (15) and basophils (16) and their activated counterparts in vivo [eosinophils (17) ], ex vivo (basophils; AM Dvorak et al., unpublished data) , and in recombinant human IL5-induced eosinophils which developed in suspension cultures of human cord blood cells (18) . In addition, we have described the endocytosis of CLC protein (19) and its intralysosomal location in monocytes and macrophages in vivo and in vitro (17) (18) (19) . Although the cellular function(s) of this lysophospholipase is still obscure, the presence of such large quantities of this enzyme in eosinophils and basophils suggests an important role in normal or pathological events associated with these lineages. The recent cloning of the gene for the CLC protein (20) and expression of the protein product (12) should aid future studies of the biological properties of this unique basophil and eosinophil constituent.
Human mast cells, in contrast to basophils, do not stain for the CLC protein by light microscopy (21). Since we noted an admixture of lineages in suspension cultures of cord blood supplemented with c-kit ligand-containing additives, we examined these cells for CLC protein using an immunogold method to detect this protein.
We found that mature basophils that differentiated in these longterm cultures contained CLC protein and have noted the subcellular distribution of this protein in relationship to activated and recovering phenotypes (AM Dvorak, unpublished data) which the mature basophils assumed over 3-14 weeks of culture. In addition to the previously identified locations (i.e., intragranular, cytoplasmic, nuclear, vesicular, and formed CLCs within granules, cytoplasm, and nucleus), CLC protein was also present in Golgi-associated smooth membrane-bound vesicles. In contrast, none of the cells in the mast cell lineage contained CLC protein, thereby providing an excellent immunomorphologic difference for their distinction from basophils arising in the same cultures.
Materials and Methods
Cell Cultures. Mononuclear cells were recovered from heparinized umbilical cord blood by differential centrifugation on Ficoll-Hypaque (Pharmacia; Piscataway, NJ) and suspended in RPMI-1640 medium (Gibco; Gaithersburg. MD) supplemented with 10% fetal bovine serum (Gibco). 50 pM 2-mercaptoethanol, 2 mM L-glutamine, penicillin (100 Ulml), streptomycin (50 pglml). and gentamycin (25 pglml). The cells were cultured in suspension at 37'C in a humidified atmosphere at 6% CO2 and 94% air. One half of the culture medium was replaced once a week with freshly prepared medium. Cells from seven individual cord bloods were prepared for suspension cultures that were additionally supplemented as follows: culture supernatant from Balblc 3T3 mouse fibroblasts; culture Supernatant from Swiss albino 3T3 mouse fibroblasts; no fibroblast supernatant; a partially purified fraction of Balbk 3T3 mouse fibroblast supernatant [MFF(s)] (5) ; recombinant human stem cell factor (SCF) (Amgen; Thousand Oaks, CA) (5) . Suspension cultures were recovered for electron microscopy at 3-, 6-, 7-, 8-, and 14-week intervals.
Antibodies to Eosinophil CLC Protein. Rabbit antisera and affinity chromatography-purified antibodies to human eosinophil crystal-derived CLC protein were prepared and characterized as previously described (9,10,13.15.16) . These antisera and antibody preparations have been extensively utilized for studies of the ultrastructural immunogold localization of CLC protein in peripheral blood eosinophils (15) and basophils (16) . in tissue eosinophils (17) . and in eosinophils induced to differentiate in cultures of IL5-stimulated umbilical cord blood progenitors (18) . Eosinophilderived CLC protein from crystals was solubilized and coupled to cyanogen bromide-activated Sepharose CL6B (0.44 mg CLC proreinlml swollen Sepharose). and uncoupled sites blocked by incubation with 0.1 mollliter lysine monohydrocholoride. A 5-ml column of the CLC protein-Sepharose conjugate was used to affinity-purify specific antibodies to the protein from antiserum of rabbits immunized with the crystal-derived prorein. Bound antibodies were eluted with 0.05 mollliter glycine-HCI buffer (pH 3). dialyzed against PBS. and used as the primary antibody for immunogold staining as described below. The specificity of the affinity-purified antibody for CLC protein was characterized by Western blotting of eosinophil and basophil lysates and crystal-derived CLC proteins ( Figure 1 ). Eosinophils from the peripheral blood of a patient with asthma were purified by negative selection using immunomagnetic separation from neutrophils according to the method of Hansel and colleagues (22). Basophils were isolated from the peripheral blood of a patient with primary basophil leukemia by centrifugation over a cushion of Ficoll-Hypaque (1.077 glml) (Pharmacia). Purified eosinophils and basophils were lysed by sonication and boiling in Laemmli SDS-PAGE sample buffer and lysates reduced with DTT (40 mM) before electrophoresis as previously described (12). Ten to 20 pg of protein in whole-cell lysates and 1 pg crystal-derived CLC protein standards were analyzed per lane on 10-20% gradient SDS-PAGE gels (Integrated Separation Systems; Natick. MA). Proteins were electrotransferred onto a nitrocellulose filter (BioRad; Hercules, CA) for probing with ACP anti-CLC antibody at a final concentration of 1 pglml. Secondary antibody was peroxidase-conjugated affinity-purified goat anti-rabbit IgG (heavy-and light-chain specific) (Biorad).
Electron Microscopy. Cultured cells were fixed in suspension for 1 hr in a mixture of 1% paraformaldehyde, 1.25% glutaraldehyde, and 0.025% CaC12 in 0.1 M sodium cacodylate buffer. pH 7.4, at 20'C. Cells were washed in 0.1 M sodium cacodylate buffer at 4°C overnight and centrifuged through molten agar in a microfuge to form an agar-embedded pellet of cells. Post-fixation of the samples in 2% collidine-buffered os04 for 2 hr at 2O' C was followed by three washes in 0.05 M sodium maleate buffer, pH 5.2, en bloc staining for 2 hr with 2% uranyl acetate, three washes in 0.05 M sodium maleate buffer, pH 5.2. dehydration in a graded series of Malum human basophil which d e veloped in an &week culture of cord blood mononuclear cells [no growth fador(s) added] is well preserved. has a polylobed granulocyte nucleus with condensed chromatin, irregular surface processes. and many cytoplasmic granules. The granules are enlarged and contain mixtures of particles. dense, concentric membrane arrays, and irregularly shaped CLCs (arrows). Some membrane-bound empty granules are also noted. Partially empty and completely empty granules in mature basophils are the ultrastructural correlates of piecemeal degranulation (PMD). Bar I 1 um.
a, * , r: alcohols, and infiltration and embedding in a propylene oxide-Epon 812 sequence. Random thin sections were prepared for immunogold staining.
lmmunogold Procedure to Localize CLC Protein. Gold grids containing 50-70-nm sections were stained at 25'C as follows: (a) 4% sodium mctaperiodate (23) (Sigma: St louis, MO). 15 min: (b) three washes for 10 min each in 0.2 pm Millipore-filtered (Fisher Scientific: Pittsburgh. PA) 20 mM Tris buffer containing 0.9% saline. 0.1% globulin-free bovine serum albumin (BSA). pH 7.6 (TBS-BSA): (c) 5 % normal goat serum in TBS-RSA. 1 hr; (d) primary affinity chromatography-purified rabbit anti-CLC (150 Vglml in TBS-BSA containing 1% Tween-20 and 1% normal goat scrum). 2 hr. 25'C: (e) three washes for 10 min each in TBS-BSA: (f) secondary gold-labeled antibody (120 dilution of 30-nm colloidal gold conjugated to goat anti-rabbit IgG Uansscn: Bromma. Sweden) in TBS-BSA containing 0.1% Tween-20. 0.4% gelatin and 1% normal goat serum, 1 hr; (g) rwo washes for 10 min each in TBS-BSA: (h) WO washes for 10 min each in distilled water.
Specificity Controls for the Demonstration of CLC Protein. Controls included the following alterations of the standard sequence: (a) omission of primary antibody; (b) substirution of normal rabbit scrum for the primary antibody; (c) substitution of solid-phase CLC prorein-absorbed primary antibody to CLC prorein. The non-reactive CLC protein-absorbed rabbit IgG control was prepared from the antiserum of the CLC proreinimmunized rabbit IgG as previously described (15.16). Briefly. all immunoreactivity of the antiscrum to CLC protein was first removed with a solid-phase CLC protein-Sepharose affinity column. An IgG fraction was then isolated from this CLC-absorbed non-reactive antiscrum wirh a protein A-Sepharosc (Sigma) affinity column. This absorbed non-reactive IgG from the CLC-immunized rabbit was substituted for the affinity-purified antibody at equivalent IgG concentration.
In all, 13 cultures of seven individual cord blood samples were examined by immunogold EM. The number of basophils was counted in each sample by LM of whole cells in whole mounts prepared from replicate samples. Overall. thin sections of -3800 differenr cultured cells were examined by EM.
Results

SpectFcity of A f i n ity -purtFea'
Antibodies to CLC Protein
Antisera from rabbits immunized with crystal-derived CLC protein recognize only a single protein band identical in size to CLC protein in whole-cell detergent lysates of eosinophils and basophils (Zhou and Ackerman, unpublished obscrvations) and in transicntly transfected monkey kidney COS cells and stably transfected CHO cells expressing recombinant CLC protein (12). To confirm the specificity of the ACP anti-CLC protein used for immunogold staining, whole-cell SDS detergent lysates of purified peripheral blood eosinophils and basophils, along with crystal-derived (9) 
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( Figure 2 ) also persist for up to 2 months when no growth factors are added to the cultures. These cells display typical polylobed nuclei with condensed chromatin and variable losses of their secretory particle-filled granules, a process termed piecemeal degranulation (Figure 2) , which is analogous to sequential losses sustained by basophils that infiltrate experimentally produced human contact allergy reactions in the skin (reviewed in 24). They also contain large numbers of intragranular CLCs ( Figure 3A) (14.16) . Such unsupplemented cultures of human cord blood cells also contain macrophages packed with secondary lysosomes. Some of the secondary lysosomes contain typical ( Figure 3B ) and atypical crystals similar to those we have identified in other circumstances (17,18) to contain CLC protein by ultrastructural immunogold analysis. Mast cells were absent in 2-month suspension cultures of unsupplemented human cord blood cells.
Distribution of CLC Protein in Mature Human
Basophils Present in Suspension Cultures of Cord Blood Cells Supplemented with Murine Fibroblast Supernatants, MFF(s), or rhSCF
Suspension Cultures (6,7 W e e k s ) Supplemented with Mouse Fibroblast Culture Supematants of Balbkor Swiss Albino Origin. Six and 6.4% of the cells in these suspension cultures were basophils by LM. By EM, all basophils were mature; basophilic myelocytes Figure 4 , shows the cytoplasm and Golgi area of a mature basophil at higher magnification Golgi area gold label is associated with small, smooth membranebound vesicles Nucleus and cytoplasm are also labeled The plasma membrane is not labeled, but subplasma membrane cytoplasmic sites are Nonparticle-filled homogeneous granules are heavily labeled (closed arrow) One particle filled granule is not labeled (open arrow) Bar = 05 pm (25) were absent. Although some basophils showed piecemeal degranulation losses from some granules, most granules contained electron-dense contents. As described, the main granules were filled with particles (16,26,27) . Variable amounts of concentric dense membranes compartmentalized some granules; many particle and membrane-containing granules and empty granules contained CLCs (14,16).
Immunogold stains detected CLC protein as in previously described sites in peripheral blood bkophils either freshly isolated from blood of a normal donor (1% basophils) (16), partially purified from blood of a patient with chronic myelogenous leukemia (30% circulating basophils) (16), or purified peripheral blood basophils from normal donors before and after stimulation with formyl methionyl leucyl phenylalanine (FMLP) (AM Dvorak et al., unpublished data). Most basophils showed some diffuse gold labeling of cytoplasm, plasma membrane, and nucleus in the 7-week cord blood cultures supplemented with Balbk 3T3 fibroblast supernatant (Figure 4) . In addition, some small cytoplasmic vesicles were labeled with 30-nm gold particles, as we have noted in FMLPstimulated cells (AM Dvorak et al., unpublished data). Mature basophils usually have poorly developed Golgi synthetic structures (25). In several cells that had better-developed Golgi structures, 30-nm gold particles were bound to smooth membrane-bound Golgi-associated vesicles (Figure 5 ) . Secretory granules were exten- sively labeled for CLC protein (Figures 4 and 5 ). This label assumed several distributions. Diffusely labeled particle-containing granules were evident (Figure 4) , and focally labeled intragranular CLCs were extensively gold labeled (16) ( Figure 6A ). Concentric dense membranes within granules were usually not labeled, but the enclosed interior particles within them often were ( Figure 6A ). Some large cytoplasmic granules were homogeneously dense. Although these were infrequently encountered, they usually were extensively and homogeneously labeled with gold ( Figure 5 ). We have identified increased numbers of similarly appearing labeled granules in peripheral blood basophils recovering from FMLP degranulation (AM Dvorak et al., unpublished data) and have suggested that they resemble primary granules, analogous to small numbers of similar granules in peripheral blood eosinophils (15). In eosinophils, these persistent, non-crystal-containing primary granules are the only granule source of CLC protein, as determined by ultrastructural immunogold studies (15,17,18) . Rarely, in the suspension cultures reported here, we noted heavily labeled, large bipyramidal and hexagonal non-membrane-bound CLCs free in the cytoplasm ( Figure  6B ) and nucleus of mature basophils. Controls for the specificity of the immunogold procedure to identify sites of CLC protein in cultured basophils were all negative. Specifically, immunogold staining after omission of the pri-mary antibody, substitution of irrelevant antibody for the primary antibody (Figure 7) , or absorption of the specific primary antibody with solid-phase CLC protein all failed to label the nucleus, cytoplasm, and granules, or CLCs within the granules, nucleus, or cytoplasm of basophils. In general. we more often found extensively dcgranulated basophils, of the piecemeal type (24). in 3-week cultures than we did at later intervals. Such cells showed extensive gold labeling of cytoplasmic, nuclear, and plasma membrane compartments (Figure 8A) , as we have found in FMLP-stimulated, piecemeal degranulating basophils of peripheral blood origin (AM Dvorak et al.. unpublished data). At later culture times, mature human basophils illustrated more gold-labeled intragranular CLCs (Figure 8B) and diffusely labeled granules than at the earlier culture times. All specificity controls for the immunogold procedure were negative. LM counts of the number of basophils in these cultures showed higher levels at 3 and 6 weeks ("16%) which dropped to -4% by 14 weeks.
Suspension Cultures Supplemented with a Partially Purified
Suspension Cultures Supplemented with Recombinant Human
Stem Cell Factor (rhSCF) and Sampled at 3-, 6-, and 14-week Intervals to Determine the CLC Protein Distribution. Mature basophils were present at all culture times when cord blood cells were cultured in rhSCF. Basophilic myelocytes were absent (25). Granule losses of the piecemeal degranulation type (24). similar to those recorded for basophils present in cultures supplemented with full fibroblast culture supernatants or with MFF(s), were noted. In general, these were more prominent in early (3-week) samples than in later ones. However, piecemeal degranulation of some basophils could be identified at all culture times. The general architecture of basophils and the distribution of CLC-protein in mature basophils in these cultures ( Figure 9A ) were similar to those of basophils in the fibroblast supernatants (Figure 7) or in the fibroblast-derived factor(s) (Figure 8 ). When cells prepared from the same cord blood (or different cord bloods) were compared over time, no differences in CLC protein-labeled sites were observed in mature human basophils (data not shown). All specificity control samples, as described for fibroblast supernatant-supplemented cultures, also were negative for subcellular labeling in basophils present in cultures supplemented with rhSCF ( Figure 9B ). LM counts of the number of mature basophils present in suspension cultures of cord blood cells supplemented with rhSCF showed progressive decreases in basophils, from 52.5% at 3 weeks to -21% at 6 weeks and 7% at 14 weeks of culture.
Immature Mast Cells and Their Progenitors That Develop in Suspension Cultures of Cora' Blood Cells Supplemented with Mouse Fibroblast Culture Supernatants, MFF(s), or rhSCF Do Not Contain CLC Protein
Immature mast cells (4) developed in all suspension cultures of hu- Figure 8 . Cord blood cells were cultured for either(A) 3 weeks or (6) 14 weeks in MFF(s) and prepared with immunogold to detect CLC protein. Extensive PMD is seen in the mature basophil in the 3-week culture (A). Many granules are empty. CLC protein is diffusely present in the cytoplasm and nucleus, as indicated by gold label, and granules do not label. Background is low. By 14 weeks of culture (e). mature basophils show less PMD; most granules contain particles and membrane arrays. Gold label indicates CLC protein in nuclear and cytoplasmic sites as well as in particle-filled granules and intragranular CLCs (arrow). Background is low. Bar = 1.5 bm.
man cord blood cells supplemented with fibroblast culture supernatants or with rhSCF. Such mast cells did not reach full maturity ( 5 ) , as did human mast cells developing in long-term co-cultures of cord blood cells and 3T3 fibroblasts (3,4) . In immunogold preparations to demonstrate CLC protein, all morphologically identifiable cells of the mast cell lineage were negative, regardless of the cord blood cultured, the time in culture (3-14 weeks), or whether suspension cultures were supplemented with mouse fibroblast culture supernatants from either of two sources, with MFF(s) or with rhSCF ( Figure IO) . Moreover, all granules displaying the individual patterns (particles, scrolls, and mixed contents) were negative. Therefore, mast cells and their progenitors did not contain CLC protein, whereas basophilic leukocytes did. In addition, and similar to basophils, all specificity controls for the immunogold procedure were negative for mast cells (data not shown).
Distribution of CLC Protein in Other Cells in Suspension Cultures of Cora' Blood Supplemented with Mouse Fibroblast Supernatants, MFF(s), or rhSCF
We have reported the presence of CLC protein, as determined by immunogold studies, in amorphous protein-like masses and in atyp-ically or typically shaped crystals in macrophages in several circumstances (17, 18) . Since these reports were related to macrophages in an eosinophil-rich culture system (18) or in tissue histiocytes in an eosinophil-rich skin rash (17) , we postulated that macrophages internalized CLC protein released from the eosinophils. Subsequently, we showed that purified human blood monocytes internalized soluble CLC protein by endocytosi?(l9). We also found CLCs in macrophages in the suspension cultures reported here ( Figure 11 ). Moreover, the recognizable crystals ( Figure 11B ) and more amorphous materials in macrophage secondary lysosomes (Figures 11A and 11C) were labeled with gold ( Figure 11 ). indicating the presence of CLC protein in these locations. Small numbers of eosinophils were also present in the suspension cultures. As before, eosinophils in the cultures showed morphological evidence of activation (18) , and CLC protein was gold labeled in a cytoplasmic and nuclear distribution (18) . Immunogold specificity controls were also negative for macrophages and eosinophils.
Neutrophilic myelocytes filled with primary azurophilic granules were present in quantity in the cultures supplemented with c-kit ligand-containing additives; they were less evident in the fibroblast culture supernatant-supplemented cultures. The nucleus, cytoplasm, and large numbers of azurophilic granules contained no gold label for CLC protein in neutrophilic myelocytes, and immunogold specificity controls were negative (data not shown).
Discussion
A post-embedding immunogold method (15) (16) (17) (18) (19) was used to show the distribution of CLC protein in human cells developed in c-kit ligand-supplemented suspension cultures of cord blood (5) that were recovered for EM at 3-, 6-, 7-, 8-, and 14-week intervals. These cultures contain representatives of the following lineages, as determined by routine EM: basophils, mast cells, macrophages, neutrophils, and small numbers of eosinophils and endothelial cells (AM Dvorak et al.. unpublished data). The findings presented here show that human basophils contain CLC protein but that human mast cells do not, confirming previous immunofluorescence and RIA analyses (13,21). Detection of CLC protein by immunogold analysis provides an additional means of identification to routine ultrastructural analysis when putative basophils and mast cells are admixed in culture systems. Furthermore, large neutrophilic myelocytes could be identified as non-members of the basophils lineage by their lack of CLC protein. Macrophages did contain CLC protein in crystals as well as amorphous protein-like masses within phagosomes, as we have described in eosinophil-enriched cultures or inflammatory disorders (17~8). These large cells with their internalized CLC protein (17) (18) (19) should not be confused with immature basophilic myelocytes based on the presence of CLC protein in membrane-bound granule-like containers. Eosinophils showed CLC protein distributions as previously described, i.e., in diffuse cytoplasmic, nuclear, and primary granule locations (15, 17, 18) . Endothelial cells did not contain CLC protein.
The presence of CLC protein in basophils (and its absence in mast cells) was a consistent finding in these studies, regardless of the source of growth factor used (c-kit ligand) (5) or the individual cord sample or culture time. CLCs have been described in human Our initial immunogold studies of the distribution of CLC protein in human basophils showed labeled, formed CLCs within granules (16) . In addition, we noted diffusely labeled granules and rare cytoplasmic vesicles that contained CLC protein (16) . These studies were extended to show that CLC protein is contained within cytoplasmic and nuclear CLCs of activated peripheral blood basophils and, during release and recovery experiments of isolated, purified peripheral blood basophils, the CLC protein was not released extracellularly (28) but was instead redistributed to cytoplasmic, nuclear, plasma membrane, and vesicular locations (28) (AM Dvorak et al., unpublished data). In particular, basophils that displayed the morphological phenotype of piecemeal degranulation had in-creased diffuse labeling of cytoplasm and nucleus, as well as labeled plasma membranes (Am Dvorak et al., unpublished data). Later, after recovery, labeling of these locations diminished and. again, the granular compartment became predominantly labeled (AM Dvorak et al., unpublished data). We also noted the appearance of a heavily labeled, newly evident, homogeneously dense granule population (AM Dvorak et al., unpublished data) that resembled the CLC protein-containing primary granules of eosinophils (15).
The distribution of CLC protein in the basophils that differentiate in c-kit ligand-supplemented suspension cultures of cord blood resembled that described before in peripheral blood basophils (16) . As in the stimulated secretory model described above (14). we found increased amounts of diffuse cytoplasmic, nuclear, and plasma membrane label in cells expressing the piecemeal degranulation phenotype. At later times in cultures in which some basophils had recovered granule contents, we noted increased numbers of CLC protein-positive particle granules, intragranular CLCs, and CLCs free in the cytoplasm and nucleus. Also noted were increased numbers of homogeneously dense, heavily labeled granules. Occasionally, we found Golgi area vesicles that were positively labeled for CLC protein; whether this represents evidence of CLC protein synthesis by basophils or Golgi trafficking of previously released and re-internalized CLC protein cannot be determined from these studies. Basophils have the capacity to endocytose proteins, some of which go directly to granules and others that traffic to Golgi structures (reviewed in 2 5 ) . In addition, we have shown that CLC protein previously released to the cell surface of mature human peripheral blood basophils is re-internalized in small vesicles from plasma membrane-bound sites (AM Dvorak, unpublished data). Since the CLC protein is unique to basophils (and eosinophils), its function in biology will be determined in biological studies of these cells, studies that will be considerably aided by reagents that have been made possible and knowledge gained by the recent cloning of the gene for the CLC protein and expression of its protein product (12,20).
